Buscar
Mostrando ítems 1-10 de 216
Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
(Elsevier, 2020)
Non-alcoholic fatty liver disease (NAFLD) currently represents an epidemic worldwide. NAFLD is the most frequently diagnosed chronic liver disease, affecting 20–30% of the general population. Furthermore, its prevalence ...
The Incapacity of the Surgeon to Identify NASH in Bariatric Surgery Makes Biopsy Mandatory
(SPRINGER, 2009)
Nonalcoholic steatohepatitis (NASH) is a morbid condition highly related to obesity. It is unclear if the macroscopic liver appearance correlates with the histopathologic findings. The goal of this prospective study was ...
Mechanism lipotoxicity in the progression from fatty liver to non-alcoholic steatohepatitis
(Nova Science Publishers, 2017)
Non-alcoholic fatty liver disease (NAFLD) is currently the most common form of chronic liver disease worldwide. A subset of these individuals develops hepatocyte damage, inflammation and fibrosis, a syndrome referral as ...
Study of Cytochrome P450 2E1 and its allele Variants in Liver Injury of Nondiabetic, Nonalcoholic Steatohepatitis Obese Women
(Sociedad de Biología de Chile, 2008)
Th17 involvement in nonalcoholic fatty liver disease progression to non-Alcoholic steatohepatitis
(Baishideng Publishing Group, 2016-11)
The nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. NAFLD encompasses a wide histological spectrum ranging from benign simple steatosis to non-Alcoholic steatohepatitis ...
The Incapacity of the Surgeon to Identify NASH in Bariatric Surgery Makes Biopsy Mandatory
(SPRINGEREstados Unidos, 2009)